Eikon Therapeutics is a biopharmaceutical company employing revolutionary technology at the interface of biology, engineering, and chemistry to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes that enable real-time, molecular-resolution measurements of protein movement in living cells.

United States

San Francisco, CA, USA

Hayward, CA, USA

Eikon Therapeutics

Healthcare

Funds breakthrough ventures and backs exceptional entrepreneurs via capital, business building resources and strategic support.

General Catalyst Partners 

Explore thousands of opportunities within the GC portfolio.